Enjoy complimentary customisation on priority with our Enterprise License!
The heart attack diagnostics market size is forecast to increase by USD 4.99 billion at a CAGR of 7.1% between 2023 and 2028. The market is witnessing significant growth due to the rising prevalence of cardiac disorders, which is driving the demand for early and accurate diagnosis. New product launches, coupled with research and development activities, are also contributing to market growth. Imaging tests, such as echocardiography and coronary angiography, drive the identification of blood flow obstruction and oxygen supply issues by providing visual representations of the heart and blood vessels. However, pricing pressure among vendors remains a challenge, as they strive to offer competitive prices without compromising on quality. The market is expected to continue its growth trajectory, as advancements in technology lead to the development of more accurate and non-invasive diagnostic tools. Additionally, increasing awareness and education about heart attacks and their early symptoms are expected to further boost market growth.
The market is expected to experience significant growth due to the rising prevalence of myocardial infarction, or heart attack, caused by unhealthy lifestyle choices such as sedentary lifestyles, smoking, and poor diet. These lifestyle factors contribute to non-communicable diseases, including cardiovascular diseases, which are major causes of heart attacks. Metabolic factors and behavioral factors, such as high blood pressure and hypertension, also play a role in the development of heart attacks. Mammography is a crucial screening tool that helps detect breast cancer early, allowing for timely intervention and improved treatment outcomes. Diagnostic tests are essential for the early detection and treatment of heart attacks. Cardiac diagnostic tests, including ECG technology and troponin tests, are commonly used to diagnose heart attacks based on symptoms such as chest pain, exhaustion, and breathing difficulty. Clinical trials and advancements in medical technology continue to introduce new diagnostic modalities, including cardiac MRI, to improve heart attack diagnosis and treatment.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The Hospitals segment is estimated to witness significant growth during the forecast period. The market is driven by the increasing prevalence of unhealthy lifestyle choices leading to non-communicable diseases such as myocardial infarction. Factors contributing to this include oxygen supply disruption due to blood flow obstruction caused by metabolic factors like high blood pressure, diabetes, and behavioral factors such as unhealthy diet, tobacco use, physical inactivity, and alcohol consumption.
Get a glance at the market share of various regions Download the PDF Sample
The Hospitals segment accounted for USD 5.03 billion in 2018. Additionally, environmental factors like air pollution also play a role. The elderly population is particularly vulnerable, with conditions like hypertension, a sedentary lifestyle, and obesity increasing the risk of heart attacks and other cardiovascular diseases. In response, healthcare technology advancements have led to the development of diagnostic tests like blood tests for troponin T, CK-MB, and creatine kinase, as well as electrocardiograms, to detect heart attacks and related conditions. Hospitals remain the largest revenue contributor in this market due to the high number of cardiac cases, including coronary artery disease, peripheral artery diseases, ischemic heart disease, and chronic diseases like hypertension. Changes in reimbursement regulations by organizations like the Centers for Medicare and Medicaid Services further drive the establishment of hospitals for cardiac diagnostic tests. Symptoms of heart attacks include chest pain, exhaustion, and breathing difficulty.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Unhealthy lifestyle choices, such as poor diet, physical inactivity, tobacco use, and excessive alcohol consumption, are significant risk factors for the development of non-communicable diseases, including cardiovascular diseases. Myocardial infarction, or heart attack, is a common consequence of blood flow obstruction caused by oxygen supply disruption.
Furthermore, metabolic factors, including high blood pressure, diabetes, and elevated cholesterol levels, as well as behavioral and environmental factors, such as stress, obesity, and air pollution, contribute to the prevalence of cardiovascular diseases. The elderly population is particularly vulnerable to heart attacks due to the increased incidence of chronic diseases, such as hypertension and sedentary lifestyle. Diagnostic tests, including blood tests for troponin T and CK-MB, and electrocardiograms, play a crucial role in identifying heart attacks. Chest pain, exhaustion, and breathing difficulty are common symptoms. Hospitalization is often necessary for treatment, which may include coronary artery disease and peripheral artery disease interventions. Ambulatory cardiac diagnostic tests are also available for early detection and monitoring. Ischemic heart disease, a type of cardiovascular disease, is a major cause of morbidity and mortality worldwide.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The rising prevalence of cardiac disorders is notably driving market growth. The market is witnessing significant growth due to the rising prevalence of coronary artery diseases (CAD), which are the leading cause of heart attacks. CAD is often characterized by coronary artery blockage, a condition that restricts blood flow to the heart. Symptoms of heart attacks include shortness of breath, nausea, and chest pain. Risk factors for CAD include smoking, sedentary lifestyles, and unhealthy diagnostics modalities such as ECG technology, electrocardiograms, angiograms, computerized cardiac tomography, and echocardiography play a crucial role in the early detection and diagnosis of heart attacks. Financial support and reimbursement facilities are essential for increasing access to these diagnostic tests, particularly in hospitals, ambulatory surgical centers, and diagnostic centers.
Furthermore, advancements in medical technology, such as cardiac MRI, CT angiography, and artificial intelligence (AI), are revolutionizing heart attack diagnostics. These noninvasive cardiac testing methods offer improved accuracy and efficiency compared to traditional imaging tests. Early detection is crucial for effective treatment and prevention of heart failure symptoms, such as shortness of breath and increased heart rate. Cardiac enzymes, including troponin, are also used for diagnosing heart attacks. Preventive care and clinical trials are essential for developing new diagnostic modalities and improving patient outcomes. The aging population and increasing healthcare expenditure further underscore the importance of accurate and efficient heart attack diagnostics. Thus, such factors are driving the growth of the market during the forecast period.
New product launches coupled with research and development activities is the key trend in the market. The market is witnessing significant growth due to the increasing prevalence of coronary artery diseases (CAD) and the need for early detection. New diagnostic modalities, such as ECG technology, Electrocardiograms, Angiograms, Computerized cardiac tomography, Coronary artery blockage detection, and Noninvasive cardiac testing, are being developed to enhance clinical outcomes. Financial support and reimbursement facilities from governments and insurance companies are driving the market growth. Symptoms of heart failure, such as shortness of breath, nausea, and chest pain, are leading to an increased number of diagnostic tests.
Furthermore, companies are focusing on developing innovative devices, such as ECG machines, Troponin tests, and cardiac enzyme tests, to improve diagnostic accuracy. Mobile vans, hospitals, ambulatory surgical centres, and diagnostic centres are being utilized to increase accessibility. Imaging tests, including echocardiography, coronary angiography, Cardiac MRI, CT angiography, and preventive care, are also contributing to market growth. Unhealthy lifestyles, sedentary lifestyles, and an aging population are increasing the demand for heart attack diagnostics. Clinical trials and research activities are ongoing to develop more advanced diagnostic devices. Medical technology companies are investing in artificial intelligence (AI) and other advanced technologies to improve diagnostic accuracy and patient outcomes. Thus, such trends will shape the growth of the market during the forecast period.
Pricing pressure among companies is the major challenge that affects the growth of the market. The market is witnessing significant growth due to the rising prevalence of coronary artery diseases (CAD) and the increasing awareness for early detection. Technologies such as ECG technology, Electrocardiograms, and noninvasive cardiac testing, including troponin tests, play a crucial role in diagnosing heart attacks. Imaging tests, such as Computerized cardiac tomography, Coronary angiography, Echocardiography, Cardiac MRI, and CT angiography, provide valuable insights into coronary artery blockage. Heart failure symptoms, such as shortness of breath and nausea, necessitate timely diagnostics.
Furthermore, financial support and reimbursement facilities from governments and insurance companies encourage the adoption of these diagnostic modalities. Mobile vans and diagnostic centers offer convenience, especially in rural areas. Unhealthy lifestyles, including smoking, sedentary lifestyles, and an aging population, contribute to the market's growth. Clinical trials and advancements in medical technology, including artificial intelligence (AI), further enhance diagnostic capabilities. Despite the competition from local players offering affordable pricing, global vendors like Abbott, Roche, and Siemens dominate the market due to their superior product quality and established brand reputation. The US, the UK, Germany, and Japan are significant markets for these vendors, with developed healthcare expenditure and a focus on preventive care. Hence, the above factors will impede the growth of the market during the forecast period
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories - The company offers heart attack diagnostics products namely Architect i1000SR.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is expected to experience significant growth due to the rising prevalence of myocardial infarction, or heart attack, caused by unhealthy lifestyle choices such as sedentary lifestyle, unhealthy diet, tobacco use, alcohol consumption, and stress. A stroke occurs when blood flow to the brain is interrupted, leading to potential brain damage and requiring immediate medical attention to minimize long-term effects. These factors lead to non-communicable diseases like cardiovascular diseases, metabolic factors, and behavioral factors, which increase the risk of heart attacks. Heart attacks occur when there is a blood flow obstruction in the coronary arteries, leading to a decrease in oxygen supply to the heart.
Furthermore, this can result in chest pain, exhaustion, and breathing difficulty. Diagnostic tests like blood tests for troponin T and CK-MB, and electrocardiograms, play a crucial role in diagnosing heart attacks. Cardiac therapeutics encompass a range of treatments aimed at managing heart conditions, including medications, surgical interventions, and lifestyle modifications to improve overall cardiovascular health. The elderly population is at a higher risk of heart attacks due to age-related factors and the prevalence of chronic diseases like hypertension, diabetes, and obesity. The healthcare technology industry is continuously innovating to improve cardiac diagnostic tests, including ambulatory tests, to provide timely and accurate diagnoses. Air pollution and other environmental factors also contribute to the risk of heart attacks and are expected to drive market growth.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
146 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 7.1% |
|
Market growth 2024-2028 |
USD 4.99 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
6.5 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 44% |
|
Key countries |
US, Germany, UK, Canada, and China |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abbott Laboratories, ACS Diagnostics Inc., Asahi Kasei Corp., AstraZeneca Plc, Beckman Coulter Inc., Bio Rad Laboratories Inc., Bionet Co. Ltd., Boston Scientific Corp., Canon Inc., F. Hoffmann La Roche Ltd., FUJIFILM Corp., General Electric Co., Hill Rom Holdings Inc., Hitachi Ltd., Koninklijke Philips N.V., Midmark Corp., Nihon Kohden Corp., SCHILLER AG, Siemens AG, and Toshiba Corp. |
|
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for Market forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
